BACKGROUND

A “rejuvenating set” is composed of different skin products. A dilemma is that these are readily available despite containing active ingredients subject to regulation. There are several reports of side effects from use of these products.

OBJECTIVE

This study aimed to assess the knowledge, attitude, and practices on Rejuvenating sets among patients.

METHODS

This is a descriptive and observational study. Respondents answered a questionnaire covering the patient’s age, sex, educational attainment, occupation, monthly income, marital status, consumer behavior and preference in selection, side effects, habits, and practices of rejuvenating set use.

RESULTS

A total of 108 participated in this study. Majority belong to the age of 18-25 years old (42.9%), are female (65.7%), single (76.9%), and unemployed (73.3%). Sunscreen was the most common product used (51.4%). Advertisements in television was the most common factor considered during purchase (28.6%) and most were purchased at drugstores (30.5%). Majority of participants used rejuvenating sets daily (40%) for 1-3 months (32.4%). Most were unaware of the possible adverse effects (56.2%) and did not consult a physician prior to use (84.9%). There was a lack in knowledge on the composition of rejuvenating sets in terms of regulated ingredients (55.2%). A few reported signs and symptoms such as redness (33.3%), dryness (28.6%), and stinging (24.8%) after use.

CONCLUSION

This study serves as a tool to increase discourse on rejuvenating sets. With the rise in popularity and availability and lack of studies on the side effects, it is imperative that further similar studies be made.

Human ; Skin Care ; Dermatology

Introduction: Primary cutaneous anaplastic large cell lymphoma (PCALCL) is an uncommonly encountered subtype of cutaneous lymphoma under the classification of CD30-positive lymphoproliferative disorders which presents histologically as large atypical lymphocytes with pleomorphic and anaplastic cytology that localizes to the dermis. Although recurrent, PCALCL usually carries a good prognosis, with 5-year survival rates ranging from 85% to 95%. Case Summary: We report a 73-year-old elderly male who consulted at our out-patient department with a 3-year and 6-month history of multifocal, gradually enlarging, erythematous nodules with dry, necrotic areas on the scalp, right auricular area, left axillary area, right forearm, and right thigh, accompanied by loss of appetite and nontender cervical, left axillary, and right inguinal lymphadenopathy. Previous skin punch biopsy and immunohistochemical stain done by the patient’s preceding dermatologist was signed out as “suggestive” of pseudolymphoma. However, management with intralesional corticosteroid injections provided no improvement. Skin punch biopsy done at our institution revealed ALK negative (-) anaplastic large cell lymphoma. Patient was then referred to an oncologist, however, the patient was lost to follow-up and succumbed to community acquired pneumonia. Conclusion This case highlights the importance of a thorough diagnostic assessment as recent studies indicate a poorer prognosis of ALK (-) cases, with overall 5-year survival rates consistently below 50%.
Lymphoma ; Lymphoma, Large-Cell, Anaplastic